SDC1 and plasma cell myeloma: Herein we aimed to evaluate a theranostic approach combining the advantageous properties of copper-64 and the high specificity of antibodies (radioimmunotheranostics) using the anti-CD138 monoclonal antibody 9E7.4 in an aggressive mouse model of multiple myeloma.